NextCure (NASDAQ:NXTC) and Shiseido (OTCMKTS:SSDOY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.
Institutional and Insider Ownership
0.2% of Shiseido shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares NextCure and Shiseido’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings & Valuation
This table compares NextCure and Shiseido’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Shiseido||$9.92 billion||2.79||$553.64 million||$1.51||45.86|
Shiseido has higher revenue and earnings than NextCure.
This is a summary of current recommendations for NextCure and Shiseido, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
NextCure currently has a consensus price target of $25.33, indicating a potential upside of 14.89%. Given NextCure’s higher possible upside, research analysts plainly believe NextCure is more favorable than Shiseido.
Shiseido pays an annual dividend of $0.36 per share and has a dividend yield of 0.5%. NextCure does not pay a dividend. Shiseido pays out 23.8% of its earnings in the form of a dividend.
Shiseido beats NextCure on 7 of the 10 factors compared between the two stocks.
There is no company description available for NextCure Inc.
Shiseido Company, Limited engages in the production and sale of cosmetics in Japan and internationally. It also produces and sells health and beauty foods, and over-the-counter drugs; and hair and beauty salon products, as well as fragrances and body care products. In addition, the company operates beauty salons and restaurants. Further, it produces and sells cosmetic raw materials, medical-use drugs, medical cosmetics, and precision and analytical equipment. The company sells its products through cosmetic stores, department stores, mass merchandising stores, drug stores, and perfumeries. Shiseido Company, Limited was founded in 1872 and is headquartered in Tokyo, Japan.
Receive News & Ratings for NextCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextCure and related companies with MarketBeat.com's FREE daily email newsletter.